In the field of drug discovery, the exploration and screening of natural products remain a powerful engine for innovation due to their immense structural novelty and diverse scaffolds. Key research areas include marine natural products as potential antimicrobial agents and botanical extracts as antifungal candidates. However, compared to combinatorial chemistry, acquiring natural products and their analogs presents significant challenges. Researchers often face hurdles such as the extreme difficulty of isolation and extraction, limited yields, and highly complex synthetic routes.
Consequently, the volume of commercially available natural products and analogs is substantially lower than that of conventional drug-like compounds. Furthermore, the prohibitive cost of rare natural products often restricts the scope of large-scale screening.
To bridge the gap in product sourcing and supply, AnyMol has meticulously aggregated structural data for natural products, analogs, and derivatives from the inventories of trusted global suppliers. Our Natural Product Series Database features over 180,000 compound structures optimized for virtual screening. Critically, the vast majority of these structures are linked to physical, in-stock compounds, significantly reducing procurement complexity and research costs.